28515226|t|A neutralizing anti-G-CSFR antibody blocks G-CSF - induced neutrophilia without inducing neutropenia in nonhuman primates
28515226|a|Neutrophils are the most abundant WBCs and have an essential role in the clearance of pathogens. Tight regulation of neutrophil numbers and their recruitment to sites of inflammation is critical in maintaining a balanced immune response. In various inflammatory conditions, such as rheumatoid arthritis, vasculitis, cystic fibrosis, and inflammatory bowel disease, increased serum G-CSF correlates with neutrophilia and enhanced neutrophil infiltration into inflamed tissues. We describe a fully human therapeutic anti-G-CSFR antibody (CSL324) that is safe and well tolerated when administered via i.v. infusion to cynomolgus macaques. CSL324 was effective in controlling G-CSF -mediated neutrophilia when administered either before or after G-CSF. A single ascending-dose study showed CSL324 did not alter steady-state neutrophil numbers, even at doses sufficient to completely prevent G-CSF -mediated neutrophilia. Weekly infusions of CSL324 (â‰¤10 mg/kg) for 3 wk completely neutralized G-CSF -mediated pSTAT3 phosphorylation without neutropenia. Moreover, repeat dosing up to 100 mg/kg for 12 wk did not result in neutropenia at any point, including the 12-wk follow-up after the last infusion. In addition, CSL324 had no observable effect on basic neutrophil functions, such as phagocytosis and oxidative burst. These data suggest that targeting G-CSFR may provide a safe and effective means of controlling G-CSF -mediated neutrophilia as observed in various inflammatory diseases.
28515226	2	35	neutralizing anti-G-CSFR antibody	T103	UMLS:C0475463
28515226	43	48	G-CSF	T103	UMLS:C0079459
28515226	59	71	neutrophilia	T038	UMLS:C3665444
28515226	89	100	neutropenia	T038	UMLS:C0027947
28515226	104	121	nonhuman primates	T204	UMLS:C0237798
28515226	122	133	Neutrophils	T017	UMLS:C0027950
28515226	156	160	WBCs	T017	UMLS:C0023516
28515226	225	235	regulation	T038	UMLS:C1327622
28515226	239	249	neutrophil	T017	UMLS:C0027950
28515226	292	304	inflammation	T038	UMLS:C0021368
28515226	343	358	immune response	T038	UMLS:C0301872
28515226	404	424	rheumatoid arthritis	T038	UMLS:C0003873
28515226	426	436	vasculitis	T038	UMLS:C0042384
28515226	438	453	cystic fibrosis	T038	UMLS:C0010674
28515226	459	485	inflammatory bowel disease	T038	UMLS:C0021390
28515226	497	502	serum	T031	UMLS:C0229671
28515226	503	508	G-CSF	T103	UMLS:C0079459
28515226	525	537	neutrophilia	T038	UMLS:C3665444
28515226	551	574	neutrophil infiltration	T038	UMLS:C0751982
28515226	589	596	tissues	T017	UMLS:C0040300
28515226	618	623	human	T204	UMLS:C0086418
28515226	636	656	anti-G-CSFR antibody	T103	UMLS:C0475463
28515226	658	664	CSL324	T103	UMLS:C0475463
28515226	725	733	infusion	T058	UMLS:C0574032
28515226	737	756	cynomolgus macaques	T204	UMLS:C0024399
28515226	758	764	CSL324	T103	UMLS:C0475463
28515226	794	799	G-CSF	T103	UMLS:C0079459
28515226	810	822	neutrophilia	T038	UMLS:C3665444
28515226	864	869	G-CSF	T103	UMLS:C0079459
28515226	908	914	CSL324	T103	UMLS:C0475463
28515226	942	960	neutrophil numbers	T058	UMLS:C0200633
28515226	1009	1014	G-CSF	T103	UMLS:C0079459
28515226	1025	1037	neutrophilia	T038	UMLS:C3665444
28515226	1046	1055	infusions	T058	UMLS:C0574032
28515226	1059	1065	CSL324	T103	UMLS:C0475463
28515226	1110	1115	G-CSF	T103	UMLS:C0079459
28515226	1126	1132	pSTAT3	T103	UMLS:C0253050
28515226	1133	1148	phosphorylation	T038	UMLS:C0031715
28515226	1157	1168	neutropenia	T038	UMLS:C0027947
28515226	1238	1249	neutropenia	T038	UMLS:C0027947
28515226	1284	1293	follow-up	T058	UMLS:C1522577
28515226	1309	1317	infusion	T058	UMLS:C0574032
28515226	1332	1338	CSL324	T103	UMLS:C0475463
28515226	1373	1383	neutrophil	T017	UMLS:C0027950
28515226	1403	1415	phagocytosis	T038	UMLS:C0031308
28515226	1420	1435	oxidative burst	T038	UMLS:C0085416
28515226	1471	1477	G-CSFR	T103	UMLS:C0080090
28515226	1532	1537	G-CSF	T103	UMLS:C0079459
28515226	1548	1560	neutrophilia	T038	UMLS:C3665444
28515226	1584	1605	inflammatory diseases	T038	UMLS:C1290884